BIOGENETICS & TECH LIMITED
Executive Summary
Biogenetics & Tech Limited is facing financial distress marked by negative equity and working capital deficits, though recent profit signals some operational improvement. The company currently relies heavily on shareholder support to meet obligations, posing risks to liquidity and long-term viability. Focused efforts on improving cash flow, reducing reliance on owner loans, and strengthening profitability are critical to restoring financial health and ensuring sustainability.
View Full Analysis Report →- Legal registered address
- C/O M Georghiades & Associates 130a Darkes Lane Potters Bar Hertfordshire United Kingdom EN6 1AF Copied!
Latest financial results as of 15 August 2025- Shareholders funds
- £1.00k
View full financial accounts- Shareholders funds
- £1.00k
- Company number
- 14174403 Copied!
Accounts
Latest annual accounts were to 30 June 2024
Next annual accounts are due by 31 March 2026
Company financial year end is on 30 June 2026
Confirmation statement
Latest confirmation statement statement dated 14 June 2025
Next statement due by 28 June 2026
Nature of business (SIC)
72110 - Research and experimental development on biotechnology
72200 - Research and experimental development on social sciences and humanities
Latest company documents
| Date | Description |
|---|---|
| 28/07/2528 July 2025 New | Confirmation statement made on 2025-06-14 with no updates |
| 06/05/256 May 2025 | Amended total exemption full accounts made up to 2023-06-30 |
| 29/03/2529 March 2025 | Total exemption full accounts made up to 2024-06-30 |
| 14/08/2414 August 2024 | Confirmation statement made on 2024-06-14 with no updates |
| 30/06/2430 June 2024 | Annual accounts for year ending 30 Jun 2024 |
More Company Information
Recently Viewed
Follow Company
- Receive an alert email on changes to financial status
- Early indications of liquidity problems
- Warns when company reporting is overdue
- Free service, no spam emails Follow this company